Search Results
Search results for "Kevin Wright"
Results found for "Kevin Wright"
- Regulation of rod photoreceptor function by farnesylated G-protein Îł-subunits
Bright illumination triggered Gαt1 translocation from the rod outer to inner segments in all three transgenic
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- Understanding Biased Signaling in GPCRs
Explore discussion ➤ This Week’s Scientific Highlight GPR61, implicated in appetite and body weight regulation
- The GPCR antibody signal that should have been there
GPRC5A antibody gives a clean signal in wild-type cells (left) that disappears in the CRISPR knockout (right
- Asking Better Questions in Science: A Practical Guide for Emerging Researchers
The expert they admire is right there, but the fear of sounding unprepared wins.
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
accidental discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
How do we prevent lean muscle loss during weight loss?
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Right panel, the fluorescent signal is displaced when, after incubating with CELT-327, cells are incubated
- Why “Displacement” Misleads You: Allosteric Binding Demystified
translational strategy, this is where 40 years of pharmacological insight meets the questions you’re asking right
- Fluorescence Polarization in GPCR Research
New generations of fluorophores with improved photostability and brightness will enhance assay sensitivity
- How System-Level GPCR Thinking Prevents Discovery Failures
But HCS only works when assays are built with rigor and powered by the right fluorescent ligands.
- How Schild Analysis Protects Your Conclusions in GPCR Research
Acting on the right signals today shapes tomorrow’s breakthroughs — and prevents delays others won’t
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
GPCR innovation is accelerating; act on the right signals today to shape tomorrow’s breakthroughs—and
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Chemokines are low molecular weight proteins that their functional activities are achieved by binding
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- Better GPCR Drug Discovery Decisions Start With Structured Learning
The ability to access the right framework, detect risk early, and act on emerging signals determines
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
It happened because the chemistry and the biology met in the right way.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
because the target is wrong—but because the chemical matter  interacting with that target lacks the right
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Acting on the right signals today prevents tomorrow’s delays—and puts you ahead when budgets and timelines
- Understanding the Journey: Catherine Demery's Path to Addiction Science
Watch Episode 172 What happens when the career you planned no longer feels right?
- Quantifying Receptor Selectivity in Modern Drug Discovery
Kenakin uses a lever analogy where: Efficacy is the weight applied.
- đź“° GPCR Weekly News, June 19 to 25, 2023
Industry News Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim
- How Collaboration Drives GPCR Discoveries
The future of discovery will belong to scientists who know how to build the right partnerships and stay
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
directly to the researchers who use them , empowering scientists to move their work forward with the right
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- đź“° GPCR Weekly News, March 4 to 10, 2024
Heptares to receive US$2.5 million milestone payment from Formosa Pharmaceuticals Are GLP-1s finding the right
- The Hidden Driver of GPCR Drug Success: Why Target Residence Time Matters More Than You Think
Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won
- Fentanyl and Xylazine: Why Breathing Fails in Overdose
Without a reversal agent for xylazine, the best defense right now is mechanistic understanding .


























